Ductal carcinoma in situ (DCIS) DCIS is an early breast cancer. It means that some cells in the lining of the ducts of the breast tissue have started to turn into cancer cells. These cells are all ...

Have you ever heard about a cancer that is "in situ"? There's a reason why it's called that -- and why it's the kind of ...

What is ductal carcinoma in situ? DCIS is a noninvasive form of breast cancer that affects the cells of the milk ducts. DCIS accounts for about 20% to 25% of US breast cancer diagnoses.

Ductal carcinoma in situ (DCIS) is considered the earliest form of breast cancer. We asked our experts at Huntsman Cancer Institute to give an overview of the disease, including symptoms and ...

On July 20, 2023, a new editorial paper was published in Oncotarget, entitled, “Multiclonality of ER expression in DCIS – Implications for clinical practice and future research.” ...

Carcinoma in situ, or stage 0 cancer, refers to precancerous cells in a limited area. It is not cancer and may not become malignant. Learn more.

Each year, more than 56,500 women are diagnosed with ductal carcinoma in situ (DCIS), a non-invasive type of breast cancer commonly referred to as Stage 0 breast cancer.

In ductal carcinoma in situ, the cells do not spread outside the ducts to other breast tissues, but in some cases, DCIS can become invasive and spread. DCIS accounts for about 20 per cent of ...

Ductal carcinoma in situ (DCIS) is a heterogeneous group of diseases that differ in biology and clinical behavior. Until 1980, DCIS represented less than 1% of all breast cancer cases. With the ...